Challenges of GLP Analog Use for People with Type 1 Diabetes: Issues with Prior Approvals and Tips for Safer Use

Diabetes Technol Ther. 2024 Jun;26(6):363-366. doi: 10.1089/dia.2024.0023. Epub 2024 Mar 20.

Authors

Satish K Garg¹, Janet Snell-Bergeon¹, Gurleen Kaur¹, Christie Beatson¹

Affiliation

¹ Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora, Colorado, USA.

PMID: 38517221
DOI: 10.1089/dia.2024.0023

No abstract available

Publication types

Review
Editorial

MeSH terms

Diabetes Mellitus, Type 1* / drug therapy
Drug Approval
Glucagon-Like Peptides / analogs & derivatives
Glucagon-Like Peptides / therapeutic use
Humans
Hypoglycemic Agents* / therapeutic use

Substances

Hypoglycemic Agents
Glucagon-Like Peptides